Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Pierre Fabre Pharmaceuticals
Entity

Pierre Fabre Pharmaceuticals

Tracked across 1 events · 9 articles · First seen Mar 03, 2026 · Last active Mar 12, 2026

Sentiment
20
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
2 20
Regulatory
Atara Biotherapeutics Schedules FDA Meeting for Tabelecleucel
Pierre Fabre Pharmaceuticals is Atara Biotherapeutics' partner for tabelecleucel. They will be meeting with the FDA to address the points from the Complete Response Letter, aiming for a resubmission of the Biologics License Application.
Mar 03, 2026 · 9 articles
NEWSDESK
Track Pierre Fabre Pharmaceuticals live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.